| Name | Title | Contact Details |
|---|
Brit-Tex Nursing Service Inc is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Grapefruit offers Health & Wellness Solutions including telehealth, tele-psychiatry/therapy, and behavioral health services. Having worked with school districts across the country during the pandemic, Grapefruit understands the administrative burdens the schools faced during the pandemic. Grapefruit knows that a successful, comprehensive program should include access along the continuum of care — from health promotion and prevention, to treatment. With a comprehensive telemedicine program, schools have the ability to address both the physical and behavioral needs of each child. Guidance Counselors, school nurses and the school administration are not equipped or trained to handle the increased need for mental and behavioral health our youth is plagued with. Grapefruit recognizes the critical nature of providing these services to children and young adults, now more than ever.
ProCare Rx is a Duluth, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Thomas Jefferson University Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Philadelphia, PA. To find more information about Thomas Jefferson University Hospital, please visit www.jeffersonhospital.org
Delphinus Medical Technologies, Inc. is an innovation leader in advanced ultrasound development, introducing a dynamic new technique to image the breast with the use of sound and water. Delphinus is committed to creating improved imaging methods that assist medical professionals to better define and diagnose breast disease, while establishing a better patient experience that can be available for all women, regardless of age, without the concern of radiation or pain. Headquartered in Plymouth, MI, Delphinus is the first company to design and manufacture a whole breast ultrasound system that utilizes a ring transducer to transmit and receive ultrasound signals. Known as SoftVue™, three critical sound characteristics are measured and refined through proprietary algorithms, advancing this technology far beyond traditional b-mode ultrasound. By collecting and defining reflection, sound speed, and attenuation data in a 360° orientation, data are gathered and reconstructed in tomographic coronal planes, providing an enriched image set presented for cross-sectional review. SoftVue has received FDA clearance for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography. Delphinus was formed in 2010 as a spin-out of Karmanos Cancer Institute [KCI] in Detroit, MI. Created by Peter Littrup, MD of Karmanos and Neb Duric, PhD of Wayne State University Detroit, MI the SoftVue technology presents a new imaging paradigm in breast disease assessment. Karmanos Cancer Institute has served as a primary investigational site for case collection and clinical studies. Delphinus holds numerous patents and proprietary assets for its innovative and scientifically-advanced works and is poised to usher in a new era of breast imaging.